Safety and efficacy of ombitasvir/paritaprevir/ritonavir ± dasabuvir and ± ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3–6)
Agarwal, K, Brown, R.S, Dumas, E.O, McCaughan, G.W, Samuel, D, Terrault, N, Brown, K.A, Mantry, P.S, Berenguer, M, Kwo, P.Y, O’leary, J, Charafeddine, M, Pilot-Matias, T.J, Shuster, D.L, Lu, W, Enejosa, J.V, Cohen, D.E, Mariño, Z, Forns, X
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Sustained Virologic Response Predicts Fibrosis Regression Measured by Fibrotest in HCV-Infected Patients
Forns, X, Welzel, T.M, Cohen, E, Jacobson, I.M, Davis, M, Reindollar, R, Hu, Y.B, Dylla, D.E, Enejosa, J.V, Trinh, R, Sulkowski, M.S
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
SAT-283 - Sustained Virologic Response Predicts Fibrosis Regression Measured by Fibrotest in HCV-Infected Patients
Forns, X., Welzel, T.M., Cohen, E., Jacobson, I.M., Davis, M., Reindollar, R., Hu, Y.B., Dylla, D.E., Enejosa, J.V., Trinh, R., Sulkowski, M.S.
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
FRI-267 - Safety and efficacy of ombitasvir/paritaprevir/ritonavir ± dasabuvir and ± ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3–6)
Agarwal, K., Brown, R.S., Dumas, E.O., McCaughan, G.W., Samuel, D., Terrault, N., Brown, K.A., Mantry, P.S., Berenguer, M., Kwo, P.Y., O’leary, J., Charafeddine, M., Pilot-Matias, T.J., Shuster, D.L., Lu, W., Enejosa, J.V., Cohen, D.E., Mariño, Z., Forns, X.
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article